US FDA approves French drugmaker Ipsen's rare bone disorder drug

Regulator approved use of the drug in girls aged 8 years and above, and 10 years and above in boys

Related Keywords

France ,French , ,Regeneron Pharmaceuticals ,Reuters ,Drug Administration ,Blueprint Medicines Corp ,Us Fda Approves French Drugmaker Ipsens Rare Bone Disorder Drug ,